News Releases Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Go Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Go Email Alerts Year All Years 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 Keywords Go Advanced Search Keywords Search Headlines Only From To Asset Types Photos Video Audio Documents Events Standard Aug 6, 2012 Pharmaceutical Industry Veteran Al Altomari Elected To Insmed's Board Of Directors Aug 2, 2012 Insmed Receives Second Composition Of Matter Patent For ARIKACE® Jul 30, 2012 Insmed Announces Planned Departure Of Chief Financial Officer Jul 24, 2012 Insmed to Host 2012 Second Quarter Earnings Conference Call Jul 10, 2012 Insmed To Present At JMP Securities 7th Annual Healthcare Conference Jul 2, 2012 Insmed Secures $20 Million Loan Agreement With Hercules Technology Growth Capital Jun 27, 2012 Insmed Announces First Patient Dosed in TARGET-NTM Phase 2 Clinical Trial of ARIKACE® in Patients with Non-Tuberculous Mycobacteria (NTM) Lung Disease May 30, 2012 Insmed Provides Corporate Update May 23, 2012 Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease May 16, 2012 Insmed Appoints Donald J. Hayden, Jr. as Executive Chairman Show 5102550100 per page«1…35363738394041…70» Stay In The Loop Want to stay up to date on our news, events, and filings? Set up your email alerts. Sign Up View the latest Insmed Investor Presentation Download